Epigenomic Insights for Personalised Medicine

We use our epigenomic know-how and proprietary workflows to provide actionable insights that complement genomic information

About Auristone

We Are A Multi-Omics Epigenetics Platform With A Focus On Asian Diseases And Population

Centred On Asian Pan Cancer

Focus on Asian-based Cancers such as Gastric Cancer, Liver Cancer, Colorectal Cancer, Renal Cell Cancer, and others

Epigenomic Know-how

Provides actionable insights through best-in-class epigenomic predictive models in addition to genomic information

Platform for Novel Discoveries

Utilizes epigenomics know-how and asian-based epigenomic datasets to drive novel drug and biomarker discoveries

Learn More

For Academic Researchers

Nano ChIP-Seq, RNA-based WTS, and bioinformatics analysis to complement your research with epigenomic information

For Healthcare Professionals

We offer actionable clinical information based on our
NGS-compatible epigenomic workflow

> 0 K

patient samples

0

Focal Disease Areas

> 0

Years Of Research

For Academic Researchers

Nano ChIP-Seq, RNA-based WTS, and bioinformatics analysis to complement your research with epigenomic information

For Healthcare Professionals

We offer actionable clinical information based on our NGS-compatible epigenomic workflow

> 0 K

patient samples

0

Focal Disease Areas

> 0

Years Of Research

Our Offerings

We offer a suite of epigenomic-based services including data analytics and biomarker and drug discovery support.

EPI-CALL™

Our flagship product that is designed to provide physicians with actionable epigenomic information

EPI-CALL™

Our flagship product that is designed to provide physicians with actionable epigenomic information

Signomax™

Our proprietary research tool for discovery and translational epigenomic research

Signomax™

Our proprietary research tool for discovery and translational epigenomic research

EPI-TOME™

Our platform for drug and biomarker discovery with a curated epigenomic database

Coming Soon

EPI-TOME™

Our platform for drug and biomarker discovery with a curated epigenomic database

Coming Soon

Publications and Resources

Epigenetic Promoter Alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer

View All Publications

Epigenomic Insights for Personalised Medicine

About Auristone

We Are A Multi-Omics Epigenetics Platform With A Focus On Asian Diseases And Population

Centred On Asian Pan Cancer

Epigenomic Know-how

Platform for Novel Discoveries

For Academic Researchers

For Healthcare Professionals

patient samples

Focal Disease Areas

Years Of Research

For Academic Researchers

For Healthcare Professionals

patient samples

Focal Disease Areas

Years Of Research

Our Offerings

EPI-CALL™

EPI-CALL™

Signomax™

Signomax™

EPI-TOME™

EPI-TOME™

Publications and Resources

Speak To Us

Follow Us

Our Offerings

Connect

Contact

Follow Us